The cost and cost-effectiveness of PPIs: GP perspectives and responses to a prescribing dilemma and their implications for the development of patient-centred healthcare

European Journal of General Practice

Volumn 9, Issue 4, 2003, Pages

  Pollock, Kristian ^a   Grime, Janet ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Concordance; Evidence based medicine; PPIs; Prescribing

Indexed keywords

GENERIC DRUG; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ARTICLE; CLINICAL PRACTICE; CONSULTATION; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DOCTOR PATIENT RELATION; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; GENERAL PRACTITIONER; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; MEDICAL PRACTICE; MORTALITY; OUTCOMES RESEARCH; PATIENT ATTITUDE; PATIENT CARE; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; QUALITATIVE ANALYSIS; STOMACH DISEASE; UNITED KINGDOM;

EID: 0347912022     PISSN: 13814788     EISSN: None     Source Type: Journal    
DOI: 10.3109/13814780309160421     Document Type: Article

References (26)

1. Dukes MNG, Haaijer-Ruskamp FM, De Joncheere CP, Rietveld AH. Drugs and Money, Prices, Affordability and Cost Containment. Amsterdam: IOS Press/WHO, 2003.
2. Huttin C. Experiences with reference pricing. In: Dukes MNG, Haaijer-Ruskamp FM, De Joncheere CP, Rietveld AH, eds. Drugs and Money, Prices, Affordability and Cost Containment. Amsterdam: IOS Press/WHO; 2003: 85-91.
3. Haaijer-Ruskamp FM. Experiences with patient charges. In: Dukes MNG, Haaijer-Ruskamp FM, de Joncheere CP, Rietveld AH, eds. Drugs and Money, Prices, Affordability and Cost Containment. Amsterdam: ISO Press/WHO; 2003: 93-6.
4. Dew K. Epidemics, panic and power: Representations of measles and measles vaccines. Health 1999;3:379-98.
5. Dopson S, Locock L, Gabbay J, Ferlie E, Fitzgerald L. Evidence-based medicine and the implementation gap. Health 2003;7:311-30.
6. Audit Commission. A Prescription for Improvement, Towards More Rational Prescribing in General Practice [report]. London: HMSO; 1994.
7. Coulter A. The Autonomous Patient, Ending Paternalism in Medical Care. London: The Nuffield Trust; 2002.
8. RPSGB. From Compliance to Concordance, Achieving Shared Goals in Medicine Taking [report]. London; 1997.
9. Prescription Pricing Authority. Update on Growth in Prescription Volume and Cost Year to March 2002 [report]. NHS; 2002.
10. Prescription Pricing Authority. PACT Centre Pages - Drugs for Dyspepsia [report]. PPA; 2002.
11. Chaplin A, Curless R, Thomson R, Barton R. Prevalence of lower gastrointestinal symptoms and associated consultation behaviour in a British elderly population determined by face-to-face interview. Br J Gen Pract 2000;50:798-802.
12. SIGN. Dyspepsia, A National Clinical Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network. 2003.
13. Ashworth M, Armstrong D, Lloyd D, Colwill S. The effects of GP prescribing of joining a commissioning group. J Clin Pharm Ther 2002;27:221-8.
14. Bashford JNR, Norwood J, Chapman SR. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. BMJ 1998;317:452-6.
15. McManus P, Marley J, Birkett DJ, Lindner J. Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia. Br J Clin Pharmacol 1998;46:409-11.
16. Westbrook JI, Duggan AE, McIntosh JH. Prescriptions for antiulcer drugs in Australia: Volume, trends, and costs. BMJ 2001;323:1338-9.
17. NICE. Guidance on the Use of Proton Pump Inhibitors in the Treatment of Dyspepsia [report]. London: NHS; 2000.
18. Pollock K, Grime J. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): Patient self-regulation of treatment may be an under-exploited resource. Soc Sci Med 2000;51:1827-39.
19. Ginsburg ME, Kravitz RL, Sandberg WA. A survey of physician attitudes and practices concerning cost-effectiveness in patient care. West J Med 2000;173:390-4.
20. Pollock K, Grime J, Blenkinsopp A. Proton Pump Inhibitors: Perspectives of Patients and their GPs [report]. Department of Medicines Management, Keele University, 1998.
21. Butler C, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: Qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ 1998;317:637-42.
22. Weiss M, Scott D. Whose rationality? A qualitative analysis of general practitioners' prescribing. Pharmaceutical Journal 1997;259:339-41.
23. Grime J, Pollock K, Blenkinsopp A. Proton pump inhibitors: Perspectives of patients and their GPs. Br J Gen Pract 2001;51:703-11.
24. Harris RA, Kuppermann M, Richter JE. Prevention of recurrences of erosive reflux esophagitis: A cost-effectiveness analysis of maintenance proton pump inhibition. Am J Med 1997;102:78-88.
25. Bolin TD. Proton pump inhibitor use. BMJ 2001;323:1339.
26. Britten N, Okoumunne O. The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: A questionnaire survey. BMJ 1997;315:1506-10.